These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Oxytocic polypeptides in human urine. WALASZEK EJ Br J Pharmacol Chemother; 1957 Jun; 12(2):223-7. PubMed ID: 13446377 [TBL] [Abstract][Full Text] [Related]
23. An evaluation of the action of substance P on the jejunum of the rabbit. BLAIR MR; CLARK BB J Pharmacol Exp Ther; 1956 Aug; 117(4):467-77. PubMed ID: 13358060 [No Abstract] [Full Text] [Related]
24. Distribution of substance P in the central and peripheral nervous system. PERNOW B Nature; 1953 Apr; 171(4356):746. PubMed ID: 13054699 [No Abstract] [Full Text] [Related]
25. Effect of intracerebroventricular bradykinin and related peptides on rabbit operant behavior. Melo JC; Graeff FG J Pharmacol Exp Ther; 1975 Apr; 193(1):1-10. PubMed ID: 1094106 [TBL] [Abstract][Full Text] [Related]
26. Bradykinin and histamine. ROCHA E; SILVA M Arch Int Pharmacodyn Ther; 1955 Oct; 103(2-3):212-20. PubMed ID: 13259733 [No Abstract] [Full Text] [Related]
27. The effect of substance P on intestinal motility in man. LILJEDAHL SO; MATTSSON O; PERNOW B Scand J Clin Lab Invest; 1958; 10(1):16-25. PubMed ID: 13555686 [No Abstract] [Full Text] [Related]
28. [Hemodynamic characteristics of polypeptide substance P compared to bradykinin and prostaglandin E1]. Chernukh AM; Oeme P; Gomazkov OA Biull Eksp Biol Med; 1980 Sep; 90(9):259-60. PubMed ID: 6159017 [TBL] [Abstract][Full Text] [Related]
29. Transmitter-peptide coexistence in the central nervous system. Grobecker H Eur Neurol; 1983; 22 Suppl 1():38-46. PubMed ID: 6192995 [TBL] [Abstract][Full Text] [Related]
30. [Role of peptides in central neural transmission: substance P, bradykinin and beta-endorphine]. Henry JL Ann Anesthesiol Fr; 1978; 19(5):391-8. PubMed ID: 29534 [No Abstract] [Full Text] [Related]
31. The influence of analgesic antipyretic drugs on the responses of guinea-pig lungs to bradykinin. Aarsen PN Br J Pharmacol Chemother; 1966 May; 27(1):196-204. PubMed ID: 5962861 [No Abstract] [Full Text] [Related]
32. A plant Kunitz-type inhibitor mimics bradykinin-induced cytosolic calcium increase and intestinal smooth muscle contraction. Andrade SS; Smaili SS; Monteforte PT; Miranda A; Kouyoumdjian M; Sampaio MU; Lopes GS; Oliva ML Biol Chem; 2012 Sep; 393(9):943-57. PubMed ID: 22944694 [TBL] [Abstract][Full Text] [Related]
33. Role of prostaglandins in renal sensory receptor activation by substance P and bradykinin. Kopp UC; Smith LA Am J Physiol; 1993 Sep; 265(3 Pt 2):R544-51. PubMed ID: 7692751 [TBL] [Abstract][Full Text] [Related]
34. [Hypothalamic peptides acting directly on organs and tissues]. Wladyslaw Z; Kubicki TI Acta Physiol Pol; 1977; 28(15):37-62. PubMed ID: 596200 [No Abstract] [Full Text] [Related]
35. Central modulation of Brewer's yeast-induced peripheral inflammation by neuropeptides bradykinin and substance P. Hore SK; Tripathi HC; Tandan SK; Kumar D Indian J Physiol Pharmacol; 1996 Oct; 40(4):367-71. PubMed ID: 9055109 [TBL] [Abstract][Full Text] [Related]
36. The inhibitory effects of local anaesthetics on the vascular flare responses to bradykinin and substance P in human skin. Dias MP; Newton DJ; McLeod GA; Khan F; Belch JJ Anaesthesia; 2008 Feb; 63(2):151-5. PubMed ID: 18211446 [TBL] [Abstract][Full Text] [Related]
38. [Effect of kinins on the central nervous system (review)]. Posokhov VV Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(5):774-8. PubMed ID: 3927638 [No Abstract] [Full Text] [Related]
39. [Relationship between proteolytic and coagulative activity and bradykinin liberation by snake venoms]. HOLTZ P; RAUDONAT HW Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 229(2):113-22. PubMed ID: 13387768 [No Abstract] [Full Text] [Related]
40. THE NEUROGENIC ACTIVITY OF HIGH POTENCY SUBSTANCE P. KRIVOY W; KROEGER D Experientia; 1963 Jul; 19():366-7. PubMed ID: 14071700 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]